logo-loader
AIM:AGL OTCQX:ANPCY

ANGLE PLC

Receive alerts
Market:
AIM
Price
14.25 GBX
Day Change
-3.39%
Market Cap:
£37.13 m
52 weeks high
37.40
52 weeks low
9.07

In brief

ANGLE PLC is a world-leading liquid biopsy company with sample-to-answer solutions.

The company's proven patent-protected circulating tumour cell (CTC) harvesting technology is known as the Parsortix® system.

Parsortix® is FDA-cleared for its intended use in metastatic breast cancer and is currently the first and only FDA-cleared medical device to harvest intact circulating cancer cells from the blood.

Snapshot

  • ANGLE's liquid biopsy given boost by peer-reviewed research
  • ANGLE PLC: Making solid commercial progress
  • ANGLE CEO says latest cancer results "may turn out to be groundbreaking"